Skip to content

Clinico-Epidemiological Profile Of Acquired Aplastic Anemia Among Children At Assiut Governorate .

Clinico_Epidemiological Profile Of Acquired Aplastic Anemia Among Children At Assiut Governorate.

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07259863
Enrollment
35
Registered
2025-12-02
Start date
2025-12-01
Completion date
2026-11-30
Last updated
2025-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired Aplastic Anaemia

Brief summary

1. Assessment the clinical presentation and epidemiological profile of children with acquired aplastic anemia. 2. Determining the possible risk factors and associated conditions contributing to the development of acquired aplastic anemia.

Detailed description

Aplastic anaemia is a term describing the common findings of pancytopenia and marrow hypoplasia from arising variety of disease states, including acquired aplastic anaemia and a variety of congenital marrow failure states(1). The global incidence of paediatric AA varies geographically, with rates of 2 to 3 cases per million per year in Europe, but higher in East Asia and certain developing regions(2) .Among Egyptian Children, inherited bone marrow failure syndromes (BMFS), including AA, constitute about 10-15%of all BMFS and up to 30% of paediatric BMFS ,with an average of 65 cases per million live births each year .Acquired AA remains the predominant from in older children and adolescent , while inherited forms are more common in younger children(3).The clinical presentation of aplastic anaemia regularly consists of symptoms associated with pancytopenia, including fatigue, pallor, bruising, bleeding, and extended susceptibility to infections(4). Identified etiologic risk factors include infections of viral origin, such as hepatitis-associated, Epstein-Barr, parvovirus, human immunodeficiency virus, varicella zoster, measles and other viruses, as well as exposure to toxic chemicals (e.g. benzene, pesticides and insecticides) and ionizing radiation (5). Over the last three decades, bone marrow transplantation (BMT) from a matched related donor (MRD) has been the treatment of choice for children with acquired AA (6) The Rationale of our study: aplastic anaemia in children is a serious ,life threatening bone marrow failure syndrome ,often resulting from immune-mediated destruction of hematopoietic stem cell triggered by factors such as viral infections, environmental toxin, or genetic predispositions and requires precise diagnosis to distinguish from inherited bone marrow failure syndromes or hypoplastic myelodysplastic syndrome to guide appropriate treatment strategies . The Research question: What is the clinico-epidemiological profile of acquired aplastic anaemia among children at Assiut governorate.

Interventions

OTHERobservational case series study no intervention

Assessment the clinical presentation and epidemiological profile of children with acquired aplastic anemia. 2.Determining the possible risk factors and associated conditions contributing to the development of acquired aplastic anemia.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
1 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* 1- Children aged 1-18 years old diagnosed with acquired aplastic anemia 2-Fulfillment of the diagnostic criteria for acquired AA 3-patient with complete medical records,including diagnostic ,labaratory and treatement data 4-Diagnosed or treated at assuit university children hospital and the central health insurance clinic at assuit Governorate (october 2020 to october 2026)

Exclusion criteria

* 1-children with congental bone marrow failure syndrome 2-patient with a history of chemotherapy or radiotherapy prior to diagnosis 2-cases with incomplete medical or insufficient medical records that prevented confirmination of diagnosis or extraction of essential study data

Design outcomes

Primary

MeasureTime frameDescription
Acquired Aplastic Anemia among childrenfrom October 2020 to October 2026Determine the clinic-epidemiological profile of acquired aplastic anemia among children at assiut governorate
determine the clinico-Epidemiological profile of acquired aplastic anemia among children at assuit governoratefrom october 2020 to october 2026To descripe and record clinical characteristic ,management,and outcomes of the included cases

Contacts

Primary ContactSara Ramadan Hassanein, Resident doctor
sararamadan25399@gmail.com+2001018426240
Backup ContactHamdy Mohamed Mohamed, Lecturer at familly medicine
dhamdy2003@med.aun.edu.eg+2001000882184

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026